Articles > Popular publications > Business Wire press releases > April-June 2006 > Tuesday, May 16

Article: Lev Pharmaceuticals to Present at Hereditary Angioedema Conference.

Article from:
Business Wire
Article date:
May 16, 2006
Copyright

NEW YORK -- Lev Pharmaceuticals, Inc. ("Lev") (OTCBB: LEVP.OB), a developer of therapeutics for inflammatory diseases, announced today that the Company will be presenting information on its ongoing Phase III study for hereditary angioedema ("HAE") at the 2006 West Coast Regional Meeting of the Hereditary Angioedema Association, May 19-21, at the DoubleTree Hotel in El Segundo, California. The presentation, to be given by Jason Bablak, the Company's Vice President, Regulatory Affairs, is scheduled for Saturday, May 20 at 10:30 am (PT).

Lev's Phase III trial, designated CHANGE (C1-Inhibitor in Hereditary Angioedema Nanofiltration Generation evaluating Efficacy), is ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Ethical Holdings plc Commences Phase III Trials In ...
PR Newswire;  April 29, 1997 ;     700+ words ... ... today announced the start of Phase III clinical trials in the United States for its combination estrogen ... has entered directly into Phase III clinical studies in the US ... this HRT combination patch, Phase III clinical trials are ongoing ...

Article: CMS Releases Stark Phase III ...
Mondaq Business Briefing;  September 4, 2007 ;     700+ words ... ... copy of the long-awaited Stark II Phase III Regulations. Overall, healthcare providers should be pleased with the Phase III Stark rules. Despite fears that ... would be drastically altered, the Phase III revisions are for the most part ...

Article: Maxim Pharmaceuticals Completes Enrollment in U.S. Malignant ...
Business Wire;  February 8, 1999 ;     700+ words ... ... the enrollment of its United States Phase III clinical trial of Maxamine ... investigator in the Phase III trial based at the ... the results from the Phase III trial and potential ... cases reported in the United States, Europe and Australia ...

Article: BioMS Medical announces lead investigator in United ...
PR Newswire;  April 20, 2007 ;     700+ words ... ... investigator in the United States for the Company's pivotal phase III clinical trial ... clearance from the United States Food and Drug ... a pivotal phase III clinical trial ... two pivotal phase III clinical trials ... 03 in the United States. It ...

Article: Neurobiological Technologies Inc. Announces Initiation of First ...
PR Newswire;  May 4, 2006 ;     700+ words ... ... initiation of the first site outside the U.S. for its global Phase III acute ischemic stroke trials for Viprinex(TM) (Ancrod ... Our goal is to develop and market drug candidates in the United States, Europe and Asia and we may seek partnerships with pharmaceutical ...

Article: Stark II, Phase III: And Still More To ...
Mondaq Business Briefing;  September 27, 2007 ;     700+ words ... ... Referrals Act, commonly known as "Stark." This Phase III Final Rule (Phase III) was published on September 5, 2007 and will ... days later, on December 5, 2007. In publishing Phase III, CMS both responds to public comments on Phase ...

Article: Chiron Concludes Phase III Program for MENJUGATE ...
Business Wire;  November 12, 2004 ;     700+ words ... ... successfully concluded its Phase III trial for MENJUGATE(R) meningococcal C vaccine in the United States and will not be filing a Biologics ... vaccine. The now-completed Phase III trial in the United States expanded the safety and immunogenicity ...

Article: Kiadis Pharma Obtains FDA Approval to Start a Phase ...
PR Newswire Europe;  February 22, 2008 ;     700+ words ... ... the start of a clinical phase III study for its product Reviroc(TM) in the United States. Reviroc(TM) is under ... for protocol design of a phase III clinical study. Kiadis ... initiate the start of a phase III study upon completion ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives